Pulmonary extranodal natural killer/T-cell lymphoma: clinical presentation, CT characteristics, and patient outcomes

被引:0
|
作者
Li, Shuang [1 ]
Fang, Xin [1 ]
Liu, Ying [1 ]
Yue, Qiang [1 ]
Yu, Jianqun [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxue Alley, Chengdu 610041, Peoples R China
关键词
Pulmonary lymphoma; natural killer/T-cell lymphoma; computed tomography (CT); survival outcome; NASAL-TYPE; LUNG; FEATURES;
D O I
10.21037/qims-23-365
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Due to the extreme rarity of pulmonary extranodal natural killer/T-cell lymphoma (ENKTCL), studies on this lymphoma type are limited. We aimed to investigate the clinical presentations, computed tomography (CT) findings, CT dynamic changes, and outcomes of patients diagnosed with pulmonary ENKTCL. Methods: We conducted a retrospective cohort study on ENKTCL, nasal type, at West China Hospital, from January 2010 to January 2023. Out of 27 initial cases with pulmonary ENKTCL, we excluded 4 due to the lack of chest CT images, resulting in a final cohort of 23 patients. Our evaluation covered clinical features, laboratory findings, CT presentations, treatment strategies, and survival outcomes. Survival analyses were performed using the Kaplan-Meier method, with log-rank tests for survival curve comparisons. Given the small sample size, our interpretation of the data is mainly descriptive. Results: The most common CT presentations in our institution was solitary or multiple nodules (7/23, 30.4%). The halo sign (78.3%) and floating vessels sign (83.3%) were commonly observed in pulmonary ENKTCL. Elevated lactate dehydrogenase (LDH) levels were observed in 20 (86.9%) patients. The median overall survival (OS) for pulmonary ENKTCL patients was 1 month; 3 cases displayed a favorable prognosis, maintaining complete remission (CR) status for 1.5-7 years after receiving chemotherapy. Chemotherapy led to improved prognosis, with a median survival of 5 months seen in patients who received chemotherapy. Patients with bilateral lung involvement had worse outcomes compared to those with unilateral lesions. Conclusions: Pulmonary ENKTCL is a rare and aggressive disease, often misdiagnosed due to nonspecific clinical and CT features. Laboratory tests, failure of antibiotic treatment, and "floating vessels sign" on enhanced CT scans may aid in diagnosis. Timely chemotherapy may improve survival, emphasizing the importance of early detection and prompt treatment.
引用
收藏
页码:8358 / +
页数:13
相关论文
共 50 条
  • [1] Pulmonary extranodal natural killer/T-cell lymphoma: clinical analysis of three cases
    胡群
    China Medical Abstracts (Internal Medicine), 2019, 36 (03) : 180 - 180
  • [2] Extranodal Natural Killer T-Cell Lymphoma
    Sacks, Chana A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06): : 562 - 562
  • [3] Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma
    Guo, Yuyan
    Li, Enxiao
    Song, Liping
    Wu, Yinying
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (06) : 750 - 756
  • [4] Survival outcomes for extranodal natural-killer T-cell lymphoma
    Shibusawa, Motoharu
    Tanimoto, Tetsuya
    LANCET HAEMATOLOGY, 2020, 7 (06): : E442 - E442
  • [5] Improved outcomes for extranodal natural killer T-cell lymphoma Comment
    Haverkos, Bradley M.
    Porcu, Pierluigi
    LANCET HAEMATOLOGY, 2020, 7 (04): : E272 - E273
  • [6] Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma
    Nevel, Kathryn S.
    Pentsova, Elena
    Daras, Mariza
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1677 - 1684
  • [7] Extranodal natural killer/T-cell lymphoma of the palate
    Peterson, Joshua M.
    Lyapichev, Kirill A.
    BLOOD, 2022, 139 (23) : 3450 - 3450
  • [8] Extranodal Natural Killer/T Cell Lymphoma, Nasal Type: A Rare Pulmonary Presentation
    Phillips, J.
    Thakore, S.
    Ninan, N. A.
    Chichra, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
    Tse, Eric
    Fox, Christopher P.
    Glover, Alexander
    Yoon, Sang Eun
    Kim, Won Seog
    Kwong, Yok-Lam
    SEMINARS IN HEMATOLOGY, 2022, 59 (04) : 198 - 209
  • [10] Solitary Lip Extranodal Natural Killer/T-Cell Lymphoma on FDG PET/CT
    Zhang, Jianhua
    Li, Shusheng
    Fan, Yan
    Li, Qian
    Nong, Lin
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 410 - 411